Investor's Business Daily on MSN25m
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback